Clinical Risks Groups 2006/7
| Clinical Risk Group
| Examples
|
| Chronic respiratory disease & Asthma that requires continuous or repeated use of inhaled or systemic steroids or with previous exacerbations requiring hospital admission
|
- Chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema; bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis and bronchopulmonary dysplasia (BPD)
- Children who have previously been admitted to hospital for lower respiratory tract disease
|
| Chronic heart disease
|
- Congenital heart disease
- Hypertension with cardiac complications
- Chronic heart failure
- Individuals requiring regular medication and/or follow-up for ischaemic heart disease
|
| Chronic renal disease
|
- Chronic renal failure
- Nephrotic syndrome
- Renal transplantation
|
| Chronic liver disease
|
- Cirrhosis
- Biliary Atresia
- Chronic hepatitis
|
| Diabetes requiring insulin or oral hypoglycaemic drugs
|
- Type 1 diabetes
- Type 2 diabetes requiring oral hypoglycaemic drugs
|
| Immunosuppression
|
- Immunusuppression due to disease or treatment
- Patients undergoing chemotherapy leading to immunosuppression
- Asplenia or splenic dysfunction
- HIV infection
- Individuals treated with or likely to be treated with systemic steroids for more than a month at a dose equivalent to prednisolone 20mgs or more per day (any age) or for children under 20 kgs a dose of 1mg/kg/day
Some immunocompromised patients may have a suboptimal immunological response to the vaccine
|
